Stockholders' Equity Note Disclosure [Text Block] | 11. Stockholders’ Equity Effective August 10, 2015, the Company effected a reverse stock split of the basis of 1:40. As such, the Company’s authorized capital was decreased from 450,000,000 11,250,000 53,278,818 1,331,977 Effective August 11, 2016, the Company amended its articles of incorporation to increase the number of authorized shares of common stock from 11,250,000 to 18,000,000 2,000,000 On December 23, 2015, the Company completed an underwritten public offering of 1,875,000 4 7,500,000 623,720 8 548,720 8 137,180 75,000 2014 Stock Option Plan On June 6, 2014, the Company’s board of directors approved a 2014 Long-Term Incentive Plan (the “2014 Plan”), which provides for the grant of stock options, restricted shares, restricted share units and performance stock and units to directors, officers, employees and consultants of the Company. Stockholder approval of the plan was obtained on August 21, 2014. The maximum number of our common shares reserved for issue under the plan is 2,750,000 The 2014 Plan is administered by the board of directors, except that it may, in its discretion, delegate such responsibility to a committee of such board. The exercise price will be determined by the board of directors at the time of grant. Stock options may be granted under the 2014 Plan for an exercise period of up to ten years from the date of grant of the option or such lesser periods as may be determined by the board, subject to earlier termination in accordance with the terms of the 2014 Plan. At July 31, 2016, 667,101 607,101 Stock Based Compensation Number Weighted Average Weighted Average of Options Exercise Price Fair Value Outstanding at February 1, 2015 1,794,875 $ 5.48 $ 8.40 Expired (22,250) $ 22.81 Forfeited (3,750) $ 4.48 Granted 422,399 $ 4.48 $ 4.15 Outstanding at January 31, 2016 2,191,274 $ 5.12 Expired (1,375) $ 10.00 Forfeited (70,000) $ 5.12 Granted 10,000 $ 2.50 $ 1.41 Outstanding at July 31, 2016 2,129,899 $ 5.10 Exercisable at July 31, 2016 1,373,952 $ 5.20 Number Exercise Expiry Number 15,000 10.00 October 9, 2017 15,000 1,250 10.00 February 1, 2018 1,250 3,750 10.00 May 1, 2018 3,750 2,000 10.00 April 1, 2019 2,000 25,000 10.00 July 30, 2022 25,000 1,629,250 5.12 June 6, 2024 1,117,000 25,000 6.00 June 10, 2024 25,000 37,500 5.12 February 3, 2025 12,500 37,500 4.48 February 25, 2025 12,500 6,250 4.80 July 6, 2025 6,250 337,399 4.40 August 18, 2026 143,702 10,000 2.50 February 25, 2026 10,000 2,129,899 1,373,952 The aggregate intrinsic value of stock options outstanding is calculated as the difference between the exercise price of the underlying awards and the fair value of the Company’s common stock. At July 31, 2016, the aggregate intrinsic value of stock options outstanding was $Nil and exercisable was $Nil (January 31, 2016: $Nil and $Nil, respectively). During the three and six months ended July 31, 2016, the Company recognized a total fair value of $ 1,654,549 2,925,910 1,234,627 2,452,511 4,633,540 2016 2015 Expected term of stock option (years) (1) 5.00 6.36 Expected volatility (2) 67.70 % 125.14 % Stock price at date of issuance $ 2.50 $ 5.20 Risk-free interest rate 1.16 % 1.75 % Dividend yields 0.00 % 0.00 % (1) (2) Share Purchase Warrants 1,645,198 Number Exercise Expiry 6,250 $4.00 November 14, 2016 6,250 $4.00 November 26, 2016 5,688 $4.00 December 24, 2016 12,451 $10.00 August 10, 2017 3,750 $10.00 August 10, 2018 60,001 $6.00 April 4, 2019 555,968 $6.00 June 10, 2019 155,052 $3.00 June 10, 2019 168,883 $6.00 July 8, 2019 29,343 $3.00 July 8, 2019 24,625 $8.00 October 23, 2019 137,180 $4.80 December 23, 2020 365,688 $4.80 June 15, 2022 36,569 (1) $4.80 June 15, 2022 15,000 $4.80 July 6, 2022 62,500 $5.11 September 1, 2022 1,645,198 (1) During the year ended January 31, 2016, the Company issued an aggregate of 479,757 4.84 4.67 2,239,000 7 158.04 0.00 2.09 15,717 (112,406) 114,225 114,225 During the six months ended July 31, 2016, the Company issued 137,180 Certain of the warrants granted during the year ended January 31, 2016 become exercisable only under certain anti-dilution performance conditions contained in the warrant agreement. The fair value of these warrants at issuance was calculated to be $ 168,500 7 153.00 0.00 2.11 Number of Weighted Average Warrants Exercise Price Outstanding at February 1, 2015 1,628,581 $ 5.74 Issued 616,937 $ 4.83 Exercised (585,709) $ 6.00 Expired (14,611) $ 9.82 Outstanding at January 31, 2016 and July 31, 2016 1,645,198 $ 5.27 |